(29 May 2021) LPV/R, LPV,IFN,HCQ- did not improve the clinical status at day 15 in hospitalized patients
An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-beta-1a and hydroxychloroquine in hospitalized patients with COVID-19 https://doi.org/10.1016/j.cmi.2021.05.020 Adaptive, controlled trial (DisCoVeRy), add-on trial to Solidarity (NCT04315948, EudraCT2020-000936-23)- The intention-to-treat population included 583 participants (lopinavir/ritonavir, n=145; lopinavir/ritonavir-IFN-beta-1a,… Continue reading "(29 May 2021) LPV/R, LPV,IFN,HCQ- did not improve the clinical status at day 15 in hospitalized patients"